Biomarkers refer to genes, molecules or certain characteristics enabling to evaluate or measure pharmacologic response to therapeutic treatment, or various pathogenic or biological processes. Categorized by their utilization in different medical procedures, biomarkers facilitate decision-taking in early clinical drug development, thus helping to detect a patient’s health state. Oncology belongs within the major diseases where biomarkers are widely used.
Supported by novel product’s introductions, fresh market entrants, as well as M&As and other related activities, the world Biomarkers Market is evolving at a colossal tempo, set to be ultimately valued at just over EUR 26 billion by end-2018. Novel technologies exploited for biomarker discovery are the foremost contributors to the Biomarkers sector. North America heads the market as the most speedily growing geographic area. Major Biomarkers Market participants encompass, among others, Abbot Laboratories, Affymetrix, Agilent, Epigenomics, Celera, GE Healthcare, and DiagnoCure.
The research reports under this MarketPublishers’ Catalogue delve deep into the Biomarkers Market and its major submarkets – discovery technologies, services market, application market, and various indications. Covering various geographies, the research reports identify and examine the principal trends, opportunities, and the factors propelling or clogging the market growth. The competitive landscape with comprehensive profiles of numerous players in the global Biomarkers Industry, forecasts throwing light on the market’s future are provided in the research reports too.
Publications found:
141
Sort by:
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Personalized Medicine Biomarkers Market is projected to expand from USD 15.99 Billion in 2025 to USD 23.34 Billion by 2031, reflecting a CAGR of 6.51%. These biomarkers, which include speci...
January 2026
186 pages
Cardiac Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cardiac Biomarkers Market is projected to expand from USD 18.41 Billion in 2025 to USD 29.23 Billion by 2031, registering a CAGR of 8.01%. These biomarkers, consisting of measurable enzymes...
January 2026
180 pages
PARP Inhibitor Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PARP Inhibitor Biomarkers Market is projected to expand from USD 942.14 Million in 2025 to USD 1563.61 Million by 2031, achieving a CAGR of 8.81%. These biomarkers, which encompass specific...
January 2026
180 pages
Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Blood-based Biomarker For Sports Medicine Market is projected to increase from USD 813.12 Million in 2025 to USD 1163.91 Million by 2031, registering a CAGR of 6.16%. These biomarkers funct...
January 2026
185 pages
Troponin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Troponin I, Troponin T, Troponin Complex, Others), By Application (Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Cardiomyopathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Troponin Market is projected to expand from USD 2.12 Billion in 2025 to USD 3.21 Billion by 2031, registering a CAGR of 7.16%. This market is characterized by the diagnostic necessity for s...
January 2026
180 pages
Biomarker Testing Market - 2024-2031
US$ 3,400.00
The Biomarker Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...
January 2026
43 pages
The 2027-2032 World Outlook for Cardiac Biomarkers
US$ 1,195.00
This study covers the world outlook for cardiac biomarkers across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cardiac biomarkers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Biomarker Systems
US$ 1,195.00
This study covers the world outlook for biomarker systems across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for biomarker systems. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Cancer Biomarkers
US$ 1,195.00
This study covers the world outlook for cancer biomarkers across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cancer biomarkers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
The 2027-2032 World Outlook for 2D in Vitro Lung Models
US$ 1,195.00
This study covers the world outlook for 2D in vitro lung models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Bio-Lubricant
US$ 1,195.00
This study covers the world outlook for bio-lubricant across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Biomarker Technologies
US$ 1,195.00
This study covers the world outlook for biomarker technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Carcinoembryonic Antigen
US$ 1,195.00
This study covers the world outlook for carcinoembryonic antigen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Liver Organs-on-Chips
US$ 1,195.00
This study covers the world outlook for liver organs-on-chips across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Neurological Biomarkers
US$ 1,195.00
This study covers the world outlook for neurological biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Renal Biomarkers
US$ 1,195.00
This study covers the world outlook for renal biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
Immunoassay for Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics, Research), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Immunoassay for Neurological Biomarkers Market, valued at USD 654.22 Million in 2024, is projected to experience a CAGR of 11.65% to reach USD 1267.29 Million by 2030. Immunoassays for neur...
November 2025
185 pages
Biomarker Discovery Market - 2025-2033
US$ 3,400.00
Biomarker Discovery Market reached US$ 17.84 Billion in 2023 and is expected to reach US$ 54.19 Billion by 2033, growing with a CAGR of 11.90% during the forecast period 2026-2033. The Biomarker Disco...
November 2025
45 pages
Global Biosensor System Market Growth 2025-2031
US$ 3,660.00
... the global market share (sales and revenue) of key companies in Biosensor System business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biosensor System market ...
November 2025
122 pages
Global Biochemical Sensor Market Growth 2025-2031
US$ 3,660.00
The global Biochemical Sensor market size is predicted to grow from US$ 25100 million in 2025 to US$ 43370 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031. The impact of th...
November 2025
138 pages
Global Biochemical Sensors Market Growth 2025-2031
US$ 3,660.00
The global Biochemical Sensors market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...
November 2025
163 pages
Global Bioelectronics and Biosensors Market Growth 2025-2031
US$ 3,660.00
The global Bioelectronics and Biosensors market size is predicted to grow from US$ 19180 million in 2025 to US$ 34670 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031. The...
November 2025
100 pages
Global Bioacoustics Sensor Market Growth 2025-2031
US$ 3,660.00
The global Bioacoustics Sensor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...
November 2025
101 pages
Global Bioacoustics Sensor System Market Growth 2025-2031
US$ 3,660.00
The global Bioacoustics Sensor System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
November 2025
91 pages
Personalized Medicine Biomarkers Market Outlook 2026-2034: Market Share, and Growth Analysis By Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others)
US$ 3,950.00
The Personalized Medicine Biomarkers Market is valued at USD 21.52 billion in 2025 and is projected to grow at a CAGR of 11.7% to reach USD 58.25 billion by 2034. Personalized Medicine Biomarkers Mark...
November 2025
160 pages
Middle East Renal Biomarkers Market Size, Share & Trends Analysis Report By Biomarker (Functional Biomarkers, Upregulated Proteins), By Diagnostic Technique (ELISA, Immunoassays), By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The Middle East renal biomarkers market size was estimated at USD 191.23 million in 2024 and is projected to reach USD 399.33 million by 2033, growing at a CAGR of 8.67% from 2025 to 2033. The burden...
November 2025
150 pages
CNS Biomarkers Market - 2025-2033
US$ 3,400.00
CNS Biomarkers Market reached US$ 5.00 billion in 2023 and is expected to reach US$ 11.00 billion by 2033, growing with a CAGR of 8.20% during the forecast period 2026-2033. The CNS Biomarkers Market...
October 2025
40 pages
Biomarker Deals: Terms Value and Trends 2019-2025
US$ 4,650.00
... information affecting biomarker market development Review of business terms and conditions of deals in the biomarker market, with focus on major trends in biomarker deal making, the companies involved and analysis of further ...
September 2025
125 pages
Europe Biomarker Technologies Market By Technology (Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC, Others), By Indication (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Country, Competition, Forecast & Opportunities, 2020-2030F
US$ 4,000.00
Market Overview Europe Biomarker Technologies Market was valued at USD 5.86 Billion in 2024 and is expected to reach USD 8.40 Billion by 2030 with a CAGR of 6.38%. As chronic diseases such as cancer,...
August 2025
130 pages
Biomarker-based Immunoassays Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva, Tissue, Urine) By Product (Reagents & Kits, Consumables), By Biomarker, By Diseases, By End-use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Biomarker-based Immunoassays Market The global biomarker-based immunoassays market size was valued at USD 5.15 billion in 2024 and is expected to reach USD 8.33 billion by 2033, growing at a CAGR of 5...
August 2025
150 pages
Middle East & Africa Biomarker-based Immunoassays Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva) By Product (Reagents & Kits, Consumables), By Biomarker, By Diseases, By End-use, By Country, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Middle East and Africa biomarker-based immunoassays market size was estimated at USD 165.4 million in 2024 and is projected to reach USD 234.2 million by 2033, growing at a CA...
August 2025
150 pages
U.S. Biomarker-based Immunoassays Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva), By Product (Reagents & Kits, Consumables), By Biomarker, By Diseases, By End Use, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The U.S. biomarker-based immunoassays market size was estimated at USD 2.17 billion in 2024 and is projected to reach USD 3.68 billion by 2033, growing at a CAGR of 5.9% from 2025...
August 2025
150 pages
Hepatic Fibrosis Biomarkers Market Size, Share & Trends Analysis Report By Product (Blood-based Kits, Saliva-based Kits), By Technology (Immunofiltration Assays, Lateral Flow Assays), By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Hepatic Fibrosis Biomarkers Market The global hepatic fibrosis biomarkers market size was estimated at USD 423.51 million in 2024 and is projected to reach USD 2,291.73 million by 2033, growing at a C...
August 2025
150 pages
Digital Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Data Collection Tools {Digital Platforms, Mobile Apps, Desktop-Based Software, Wearable, Others} v/s Data Integration Systems), By Type (Novel Digital Biomarkers, Original Digital Biomarkers, Approved Digital Biomarkers), By Therapeutic Area (Cardiovascular Diseases, Sleep & Movement Diseases, Neurodegenerative Disorders, Psychiatric Disorder, Others), By End User (Biotechnology & Pharmaceutical Companies, Payers, Providers, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Digital Biomarkers Market was valued at USD 3.49 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 14.88% through 2030. Digi...
August 2025
170 pages
Digital Biomarkers: Global Markets
US$ 4,650.00
: The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030....
July 2025
129 pages
Non-alcoholic Steatohepatitis Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers, Others), By End User (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market was valued at USD 1.81 Billion in 2024 and is projected to reach USD 6.27 Billion by 2030, growing at a CAGR of 22.97...
June 2025
183 pages
